Paper of the MonthFeatured Slider
Research Paper of the month: Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

Jes Olesen, winner of the 2021 Brain Prize
I am very pleased to be asked for an interview on the occasion on my receipt of The Brain Prize. EAN is very close to my heart and I regard it as…